CLINICAL TRIAL
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.

Epilepsy Research 2009 September
PURPOSE: Valproate (VPA) administration may be associated with adverse metabolic effects, among is hyperammonemia, which could suggest metabolic abnormalities as carnitine deficiency. This study aimed to evaluate the risk frequency of hyperammonemia and abnormal carnitine levels in children receiving VPA who were otherwise free of neurological or obvious nutritional problems.

METHODS: Ammonia levels were prospectively evaluated in 60 epileptic children with primary epilepsy free of neurological or nutritional problems and were treated with VPA for at least 1 year. Forty healthy children were included as controls. Ammonia levels were correlated with total carnitine (TC), free carnitine (FC), acylcarnitine (AC) and AC/FC ratio. The abnormal ammonia and carnitine levels were also re-checked after 3 months treatment with L-carnitine.

RESULTS: Compared to pre-treatment and control levels, the mean TC and FC were lower (p<0.001) while ammonia (p<0.01), AC (p<0.05) and AC/FC ratio (p<0.01) were higher. In the treated group of epileptics, TC and FC were negatively associated with ammonia (r=-0.896, p<0.0001; r=-0.935, p<0.0001). Significant associations were found between FC and AC/FC levels and patient's age (FC; r=0.457, p<0.05, AC/FC; r=-0.435, p<0.05) and dose of VPA (FC; r=-0.753, p<0.001, AC/FC; r=0.591, p<0.01). Ammonia was correlated with patients' age (r=-0.532, p<0.01) and dose of VPA (r=0.673, p<0.01). The abnormal ammonia and carnitine levels were returned to normal after L-carnitine supplementation.

CONCLUSIONS: Epileptic children treated with VPA and free of neurological disabilities are at risk for hyperammonemia that may be associated with hypocarnitinemia. Patients will benefit from early recognition and preventive measures as carnitine supplementation.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app